Novo Nordisk A/S
Novo Nordisk A/S – Share repurchase programme
Novo Nordisk A/S – Share repurchase programme
Bagsværd, Denmark, 22 February 2021 – On 3 February 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 17 billion to be executed during a 12-month period beginning 3 February 2021.
Under the programme initiated 3 February 2021, Novo Nordisk will repurchase B shares for an amount up to DKK 3.0 billion in the period from 3 February 2021 to 3 May 2021.
Since the announcement as of 15 February 2021, the following transactions have been made:
Number of B shares | Average purchase price | Transaction value, DKK | |
Accumulated, last announcement | 848,375 | 377,636,383 | |
15 February 2021 | 115,000 | 462.36 | 53,170,845 |
16 February 2021 | 115,000 | 459.60 | 52,854,029 |
17 February 2021 | 115,000 | 460.92 | 53,005,632 |
18 February 2021 | 110,000 | 461.40 | 50,754,360 |
19 February 2021 | 115,000 | 455.58 | 52,391,244 |
Accumulated under the programme | 1,418,375 | 639,812,494 |
The details for each transaction made under the share repurchase programme are published on novonordisk.com.
With the transactions stated above, Novo Nordisk owns a total of 40,331,566 B shares of DKK 0.20 as treasury shares, corresponding to 1.7% of the share capital. The total amount of A and B shares in the company is 2,350,000,000 including treasury shares.
Novo Nordisk expects to repurchase B shares for an amount up to DKK 17 billion during a 12-month period beginning 3 February 2021. As of 19 February 2021, Novo Nordisk has since 3 February 2021 repurchased a total of 1,418,375 B shares at an average share price of DKK 451.09 per B share equal to a transaction value of DKK 639,812,494.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 45,000 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com, Facebook, Twitter, LinkedIn, YouTube.
Further information
Media: | ||
Anne Margrethe Hauge | +45 3079 3450 | amhg@novonordisk.com |
Michael Bachner (US) | +1 609 664 7308 | mzyb@novonordisk.com |
Investors: | ||
Daniel Muusmann Bohsen | +45 3075 2175 | dabo@novonordisk.com |
Valdemar Borum Svarrer | +45 3079 0301 | jvls@novonordisk.com |
Ann Søndermølle Rendbæk | +45 3075 2253 | arnd@novonordisk.com |
Mark Joseph Root | +45 3079 4211 | mjhr@novonordisk.com |
Kristoffer Due Berg (US) | +1 609 235 2989 | krdb@novonordisk.com |
Company announcement no. 14 / 2021
Attachment
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biogen Inc.4.3.2021 13:49:08 CET | Press release
Biogen Announces Plans to Build a New, State-of-the-Art Gene Therapy Manufacturing Facility in Research Triangle Park, North Carolina
Investeringsforeningen PFA Invest4.3.2021 13:33:04 CET | Pressemeddelelse
Anmodning om ophævelse af suspension af samtlige afdelinger i Investeringsforeningen PFA Invest
Sveriges Riksbank4.3.2021 13:31:34 CET | Press release
Update: USD TENDER OPERATION ANNOUNCEMENT
Vestjysk Bank A/S4.3.2021 13:16:51 CET | Press release
Vestjysk Bank A/S has issued DKK 140 million Senior Non-Preferred
Vestjysk Bank A/S4.3.2021 13:16:41 CET | Pressemeddelelse
Vestjysk Bank A/S udsteder DKK 140 millioner Senior Non-Preferred
Bombardier Inc.4.3.2021 13:02:07 CET | Press release
Bombardier Provides 2025 Financial Targets and Highlights Progress on Key Earnings Growth and Cash Generation Drivers at Virtual Investor Day
Hatch Ltd4.3.2021 13:01:56 CET | Press release
Hatch celebrates 65th anniversary with release of new campaign, "Positive change: leadership for a better world"
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom